More Than 2 Million Children Living with HIV Stand to Benefit from Scientific Advance
KAMPALA, Uganda, Dec. 1 /PRNewswire/ -- Abbott today made its new lower- strength...
#5: Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Abbott Will Register and Make the New Lower-Strength lopinavir/ritonavir Tablet Available in More Than 150 Countries to Support Broad Access for the More Than 2 Million Children Living...
'Cool Globe' Sculpture Promotes Environmental Protection Awareness
NORTH CHICAGO, Ill., Nov. 9 /PRNewswire/ -- To help raise environmental awareness in Lake County, Abbott (NYSE: ABT)...
#3: ABT News GE to Acquire Abbott's in vitro and Point-of-Care Diagnostics Businesses for $8.13 Billion, Broadening Capabilities in Growing Global Industry
FAIRFIELD, Conn. and ABBOTT PARK, Ill.--(BUSINESS WIRE)--General Electric Company (NYSE: GE) and Abbott (NYSE: ABT), a global
leader in medical diagnostic instruments and tests, announced...
--(BUSINESS WIRE)--Stress is one gift nobody wants to receive over the holidays, and some people get more than their share. But there are ways to keep your holiday carefree. Radio News Feature...
--(BUSINESS WIRE)--The holiday season can be an exciting time, but traveling and time with visitors can cause stress, which may ultimately trigger illnesses. A recent survey of mothers around the...
